Article

2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Therapies
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le samedi 16 novembre 2019
Doi : 10.1016/j.therap.2019.10.003
Received : 28 January 2019 ;  accepted : 18 October 2019
Urticaire sévère avec récidive compliquée d’angiœdème sous sécukinumab : à propos d’un cas
Severe urticaria with recurrence complicated by angioedema under secukinumab: A case report
 

Nihal Bekkali a, , Corinne Simon b, Raphaelle Binois a, Éric Estève a
a Service de dermatologie, CHR d’Orléans, 14, avenue de l’Hôpital, CS 86709, 45067 Orléans cedex 2, France 
b Centre régional de pharmacovigilance, centre Val-de-Loire, CHRU de Tours, 37044 Tours, France 

Auteur correspondant.

Mots clés : Sécukinumab, Angiœdème, Urticaire, Hypersensibilité

Keywords : Secukinumab, Angioedema, Urticaria, Hypersensitivity



 Ce cas a été notifié au centre régional de pharmacovigilance Centre Val de Loire le 02 mars 2017 (no 17222).



© 2019  Société française de pharmacologie et de thérapeutique@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline